Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial)

Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Takashi Takeshita, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Takayuki Kobayashi, Yuriko Katagiri, Masahiro Kitada, Nobumoto Tomioka, Yasuo Miyoshi, Hideo Shigematsu, Minoru Miyashita, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji

Open source

DOI: 10.1007/s10549-024-07414-7
Published: 2024-06-26
Container: Breast Cancer Research and Treatment
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10549-024-07414-7,
  title = {Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial)},
  author = {Takayuki Iwamoto and Naoki Niikura and Kenichi Watanabe and Takashi Takeshita and Yuichiro Kikawa and Kokoro Kobayashi and Nobutaka Iwakuma and Takuho Okamura and Takayuki Kobayashi and Yuriko Katagiri and Masahiro Kitada and Nobumoto Tomioka and Yasuo Miyoshi and Hideo Shigematsu and Minoru Miyashita and Hiroshi Ishiguro and Norikazu Masuda and Shigehira Saji},
  year = {2024},
  journal = {Breast Cancer Research and Treatment},
  doi = {10.1007/s10549-024-07414-7},
  url = {https://doi.org/10.1007/s10549-024-07414-7}
}

RIS

TY  - JOUR
TI  - Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial)
AU  - Takayuki Iwamoto
AU  - Naoki Niikura
AU  - Kenichi Watanabe
AU  - Takashi Takeshita
AU  - Yuichiro Kikawa
AU  - Kokoro Kobayashi
AU  - Nobutaka Iwakuma
AU  - Takuho Okamura
AU  - Takayuki Kobayashi
AU  - Yuriko Katagiri
AU  - Masahiro Kitada
AU  - Nobumoto Tomioka
AU  - Yasuo Miyoshi
AU  - Hideo Shigematsu
AU  - Minoru Miyashita
AU  - Hiroshi Ishiguro
AU  - Norikazu Masuda
AU  - Shigehira Saji
PY  - 2024
JO  - Breast Cancer Research and Treatment
DO  - 10.1007/s10549-024-07414-7
UR  - https://doi.org/10.1007/s10549-024-07414-7
ER  -

APA

Iwamoto, T., Niikura, N., Watanabe, K., Takeshita, T., Kikawa, Y., Kobayashi, K., Iwakuma, N., Okamura, T., Kobayashi, T., Katagiri, Y., Kitada, M., Tomioka, N., Miyoshi, Y., Shigematsu, H., Miyashita, M., Ishiguro, H., Masuda, N., & Saji, S. (2024). Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial). Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07414-7

Source records

crossref · retrieved 2026-09-26T15:36:14.183Z